Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 289

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 289
---
 event would any of the following, alone or in combination, be deemed to constitute, or be taken into account in determining whether there has been or will be a “SPAC Material Adverse Effect”: (a)any change in applicable Laws or GAAP or any interpretation thereof following the date of the Business Combination Agreement; (b)any change in interest rates or economic, political, business or financial market conditions generally; (c)the taking of any action or failure to take any action as required to be taken under the Business Combination Agreement; (d)any natural disaster (including hurricanes, storms, tornados, flooding, earthquakes, volcanic eruptions or similar occurrences), epidemic or pandemic (including any action taken or refrained from being taken in response to COVID -19or any COVID -19Measures or any change in such COVID -19measures or interpretations following the date of the Business Combination Agreement), acts of nature or change in climate; (e)any acts of terrorism or war, the outbreak or escalation of hostilities, geopolitical conditions, local, national or international political conditions; (f)any matter set forth in SPAC Disclosure Letter; (g)any action taken by, or at the request of, the Company or MultiplAI; (h)the announcement of the Business Combination Agreement and consummation of the transactions, including any termination of, reduction in or similar adverse impact (but in each case only to the extent attributable to such announcement or consummation), on SPAC’s relationships, contractual or otherwise, with third parties (other than such impact on licenses with governmental authorities, which impact shall not be excluded); or 141 (i)any change in the trading price or volume of the SPAC Units, SPAC Ordinary Shares or Public Warrants (provided that the underlying causes of such changes referred to in this items (i) may be considered in determining whether there is a SPAC Material Adverse Effect except to the extent such cause is otherwise excluded under any of items (a) through (h) of this definition); provided, further, that in the case of each of items (a), (b), (d) and (e), any such event to the extent such event disproportionately and adversely affects SPAC relative to other similarly situated special purpose acquisition companies shall not be excluded from and shall be taken into account in the determination of whether there has been, or would reasonably be expected to be, a SPAC Material Adverse Effect, but only to the extent of the incremental disproportionate effect on SP